2023
Changes in opioid prescribing in veterans with headache during the COVID‐19 pandemic: A regression discontinuity in time analysis
Wang K, Fenton B, Skanderson M, Black A, Becker W, Seng E, Anthony S, Guirguis A, Altalib H, Kimber A, Lorenze N, Scholten J, Graham G, Sandbrink F, Sico J. Changes in opioid prescribing in veterans with headache during the COVID‐19 pandemic: A regression discontinuity in time analysis. Headache The Journal Of Head And Face Pain 2023, 63: 1295-1303. PMID: 37596904, DOI: 10.1111/head.14605.Peer-Reviewed Original ResearchMorphine equivalent daily dosesVeterans Health AdministrationNumber of prescriptionsOpioid prescribingOpioid prescriptionsLong-term opioid therapyMME/dayRetrospective cohort studyEquivalent daily dosesCOVID-19 pandemicOpioid therapyPre-pandemic periodCohort studyDaily doseChronic painOutpatient visitsPrevious diagnosisDaily dosesMean ageSubgroup analysisHeadache disordersOpioid accessHealth AdministrationPrescribingCoronavirus disease
2022
Long-Term Opioid Therapy and Overdose in Patients With and Without Cancer (CO203A)
Merlin J, Black A, Troszak L, Giannitrapani K, Lorenz K. Long-Term Opioid Therapy and Overdose in Patients With and Without Cancer (CO203A). Journal Of Pain And Symptom Management 2022, 63: 1065-1066. DOI: 10.1016/j.jpainsymman.2022.04.013.Peer-Reviewed Original ResearchLong-term opioid therapyOpioid therapyOpioid prescriptionsOpioid overdoseElectronic health record databaseTerm opioid therapyCancer pain managementRetrospective cohort studyCox proportional hazardsOpioid overdose riskHealth record databaseYears of ageRole of cancerOpioid receiptCohort studyMost patientsPain managementOutpatient visitsInpatient admissionsVHA careOpioid risksDose/Inclusion criteriaOverdose riskLatent growth mixture modeling